Clinical Research Directory
Browse clinical research sites, groups, and studies.
68Ga-NOTA-RM26 PET/CT in Glioma Patients
Sponsor: Peking Union Medical College Hospital
Summary
The aim of this study was to investigate the value of 68Ga-NOTA-RM26, an antagonist targeting gastrin-releasing peptide receptor (GRPR) PET tracer, in the diagnosis of high WHO grade glioma and prediction the grade of glioma using positron-emission tomography/computed tomography (PET/CT).
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2022-10-01
Completion Date
2024-05-31
Last Updated
2024-05-14
Healthy Volunteers
No
Conditions
Interventions
68Ga-RM26
Intravenous injection of one dosage of 74-185 MBq(2-5 mCi) 68Ga-RM26. Tracer doses of 68Ga- RM26 will be used to image lesions of glioma by PET/CT.
Locations (1)
Chinese Academy of Medical Science & Peking Union Medical College Hospital
Beijing, Beijing Municipality, China